Author of the publication

Modeling the effect of deregulated proliferation and apoptosis on the growth dynamics of epithelial cell populations in vitro

, , and . Biophysical journal, 88 (1): 62–75 (2005)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

An individual cell-based model of the growth regulation of epithelial cell-populations in-vitro., , and . German Conference on Bioinformatics, page 47-51. (2003)Ontology-Based Modelling of Web Content: Example Leipzig Health Atlas., , , , , and . Semantic Applications, Springer, (2018)On the biomechanics of stem cell niche formation in the gut--modelling growing organoids, , , , , , and . The FEBS journal, 279 (18): 3475–3487 (2012)Massive transcriptional perturbation in subgroups of diffuse large B-cell lymphomas, , , , , , , , , and 1 other author(s). PloS one, 8 (11): e76287 (2013)A biomathematical model of human erythropoiesis under erythropoietin and chemotherapy administration, , , and . PloS one, 8 (6): e65630 (2013)MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas, , , , , , , , , and 5 other author(s). British journal of haematology, 142 (5): 732–744 (2008)Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60), , , , , , , , , and 16 other author(s). The Lancet Oncology, 9 (2): 105–116 (2008)Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer, , , , , , , , , and 10 other author(s). International journal of cancer. Journal international du cancer, 116 (5): 692–702 (2005)Dose-escalated CHOP plus etoposide (MegaCHOEP) followed by repeated stem cell transplantation for primary treatment of aggressive high-risk non-Hodgkin lymphoma, , , , , , , , , and . Blood, 107 (8): 3058–3064 (2006)Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers, , , , , , , , , and 8 other author(s). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (35): 5887–5892 (2009)